Your Trusted Partner in Analysis and Biosensors

Cutting-edge Innovations for Your Research

Our Innovations Technology

Patented Bridge-It® Assay Platform

Mediomics’ Bridge-It® assay was based on a simple idea of splitting the DNA binding site for a protein into two DNA half-sites. The presence of the DNA-binding protein or one of its ligands can be detected by FRET (fluorescence resonance energy transfer).

Patented FRET-PINCER® Assay Platform

The patent-protected FRET-PINCER® Assay system detects the concentration of the target molecule by bringing together complementary single-stranded DNAs and their attached fluorophores to produce fluorescent light through FRET (fluorescence resonance…

Patented TRF-PINCER® Assay Platform

The patent-protected TRF-PINCER® Assay platform system detects the concentration of the target molecule by bringing together complementary single-stranded DNAs and their attached fluorophores to produce fluorescent light with Time-Resolved Fluorometry (TRF)…

Our platform technologies have already been adapted for the detection of a range of important macromolecules, including cAMP, tryptophan, S-adenosyl methionine, PDE, biotin, insulin, C-peptide, albumin, C-reactive protein (hCRP), IgG, IgM, E. coli, and others.

Featured Product

References

If you would like to add a publication that uses one of our products, please contact us and we would be happy to include it.

Technology History

Mediomics’ Bridge-it® assay (Fig. 1A) was based on a simple idea of splitting the DNA binding site for a protein into two DNA “half-sites”.

References

If you would like to add a publication that uses one of our products, please contact us and we would be happy to include it.

Technology History

Mediomics’ Bridge-it® assay (Fig. 1A) was based on a simple idea of splitting the DNA binding site for a protein into two DNA “half-sites”.